The price of Stoke Therapeutics Inc (NASDAQ: STOK) closed at $6.30 in the last session, up 5.18% from day before closing price of $5.99. In other words, the price has increased by $+0.31 from its previous closing price. On the day, 1161425 shares were traded.
Ratios:
We take a closer look at STOK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.13 and its Current Ratio is at 9.13. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
BofA Securities Upgraded its Underperform to Neutral on May 01, 2023, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 19 ’24 when Kaye Edward M. MD sold 11,150 shares for $6.10 per share. The transaction valued at 67,999 led to the insider holds 69,350 shares of the business.
Ticho Barry sold 4,116 shares of STOK for $25,102 on Mar 19 ’24. The CHIEF MEDICAL OFFICER now owns 11,469 shares after completing the transaction at $6.10 per share. On Mar 19 ’24, another insider, Tulipano Stephen J, who serves as the CFO of the company, sold 4,116 shares for $6.10 each. As a result, the insider received 25,102 and left with 20,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 280.87M and an Enterprise Value of 68.65M. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.41 while its Price-to-Book (P/B) ratio in mrq is 1.61. Its current Enterprise Value per Revenue stands at 7.43 whereas that against EBITDA is -0.62.
Stock Price History:
Over the past 52 weeks, STOK has reached a high of $14.00, while it has fallen to a 52-week low of $3.35. The 50-Day Moving Average of the stock is 5.75, while the 200-Day Moving Average is calculated to be 6.07.
Shares Statistics:
According to the various share statistics, STOK traded on average about 227.21K shares per day over the past 3-months and 364.45k shares per day over the past 10 days. A total of 39.44M shares are outstanding, with a floating share count of 27.76M. Insiders hold about 37.83% of the company’s shares, while institutions hold 65.47% stake in the company. Shares short for STOK as of Feb 29, 2024 were 3.76M with a Short Ratio of 16.57, compared to 4.13M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.43% and a Short% of Float of 13.53%.
Earnings Estimates
The company has 8 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.63 for the current quarter, with a high estimate of -$0.48 and a low estimate of -$0.71, while EPS last year was -$0.65. The consensus estimate for the next quarter is -$0.61, with high estimates of -$0.55 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$2.26 and -$2.48 for the fiscal current year, implying an average EPS of -$2.41. EPS for the following year is -$2.3, with 8 analysts recommending between -$1.67 and -$2.97.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for STOK’s current fiscal year. The highest revenue estimate was $12M, while the lowest revenue estimate was $6M, resulting in an average revenue estimate of $9.62M. In the same quarter a year ago, actual revenue was $12.4M, down -22.50% from the average estimate.
